Carlo M. Croce

Carlo Maria Croce (born December 17, 1944) is an Italian-American professor of medicine at Ohio State University, specializing in oncology and the molecular mechanisms underlying cancer.

[2] During that time, tobacco companies used Croce's research into fragile histidine triad (FHIT) to argue that lung cancer was an inherited condition.

[3] In 2004, Croce moved to Ohio State University (OSU), where he had been an external advisor since 1988, receiving an initial salary of $475,000 and taking with him over 100 staff.

[8] Although Croce publicly stated that he was given no reason for his removal as chair, OSU produced a letter that provided such reasons, including that Croce "failed to provide appropriate evaluation and guidance for the faculty", "has been resistant to following normal procedures for developing faculty letters of offer and determining salary parameters", "has also not met some of the basic chair responsibilities regarding governance of the Department", and "is deficient in his ability to manage university and department finances".

[12] In 2018, two cancer researchers at OSU, Samson T. Jacob and Ching-Shih Chen, both colleagues and co-authors with Croce on two papers each, were found to have engaged in scientific misconduct.

Croce himself was not found guilty of research misconduct, but investigators criticized his management, and OSU told him to retract multiple additional papers.

[22][23][24] On May 10, 2017, Croce filed a lawsuit against The New York Times and several of its writers and editors for defamation, invasion of privacy, and intentional infliction of emotional distress based on their reporting of the scientific misconduct allegations.

[40] In December 2022, Croce was ordered by the Franklin County (OH) Court of Common Pleas to pay Kegler Brown Hill + Ritter over one million dollars for unpaid invoices.

[2] Croce privately collects Italian Renaissance and Baroque paintings, with a claimed ability to identify and purchase genuine masters for a fraction of their worth.

[42] In 2006 Croce received the Clowes Memorial Award from the American Association for Cancer Research for his discoveries of the molecular mechanisms of leukemia.